GAS5 and hepatocellular carcinoma: Specifically, downregulation of lncRNA growth arrest-specific 5 (GAS5) in HCC promotes proliferation and drug resistance through the decrease of phosphatase and tensin homolog (PTEN) expression (Wang et al., 2020).